Significant Ownership of ADAR1 Capital Management, LLC

Signature - Title
/s/ Daniel Schneeberger - Daniel Schneeberger, Manager
Location
Austin, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ADAR1 Capital Management, LLC.

Notify me when ADAR1 Capital Management, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of ADAR1 Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IKT Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value 9.9% $25,384,774 +$9,909,386 12,692,387 +64% ADAR1 Capital Management GP, LLC 31 Dec 2025
EQ Equillium, Inc. Common Stock, par value $0.0001 per share 9.9% $8,857,442 6,194,882 ADAR1 Capital Management GP, LLC 30 Sep 2025
GRCE Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $5,836,720 1,648,791 ADAR1 Capital Management GP, LLC 31 Dec 2025
KPRX Kiora Pharmaceuticals, Inc. Common Stock, par value $0.01 per share 9.9% $1,095,537 365,179 ADAR1 Capital Management GP, LLC 30 Jun 2025
ACST Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% 1,534,254 +2.1% ADAR1 Capital Management GP, LLC 30 Sep 2025
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share 7.9% $3,184,456 1,014,158 ADAR1 Capital Management, LLC 31 Dec 2025
OVID Ovid Therapeutics Inc. Common Stock, par value $0.001 per share 6.9% $14,111,932 9,284,166 ADAR1 Capital Management, LLC 31 Dec 2025
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share 6.9% $483,309 58,230 ADAR1 Capital Management, LLC 31 Dec 2025
ADGM Adagio Medical Holdings, Inc. Common Stock, par value $0.0001 per share 5.7% $1,205,447 1,205,447 ADAR1 Capital Management, LLC 31 Dec 2025
SPRB Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share 5.4% $4,796,020 58,000 ADAR1 Capital Management, LLC 31 Dec 2025
PCSC Perceptive Capital Solutions Corp Class A Ordinary Shares, par value $0.0001 per share 5.1% $6,202,258 456,720 ADAR1 Capital Management, LLC 31 Dec 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 4.9% $1,270,559 298,955 ADAR1 Capital Management, LLC 31 Dec 2024
IBIO iBio, Inc. Common Stock, par value $0.001 per share 4.4% $3,433,244 -$1,123,655 1,351,671 -25% ADAR1 Capital Management, LLC 31 Dec 2025
ZURA ZURA BIO LIMITED Class A Ordinary Shares, par value $0.0001 per share 3.2% $2,991,241 2,077,251 ADAR1 Capital Management, LLC 31 Dec 2024
PRTA Prothena Corporation Public Limited Company Ordinary Shares, par value $0.01 per share 2.7% $14,338,396 -$18,601,691 1,469,098 -56% ADAR1 Capital Management, LLC 30 Sep 2025
BIOA BioAge Labs, Inc. Common Stock, par value $0.00001 per share 0.4% $2,419,746 -$32,157,900 135,560 -93% ADAR1 Capital Management, LLC 31 Dec 2025
CLRB Cellectar Biosciences, Inc. Common Stock, $0.00001 par value per share 0.1% 2,962 ADAR1 Capital Management, LLC 30 Jun 2025
KROS Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 -$85,258,156 0 -100% ADAR1 Capital Management, LLC 15 Oct 2025

Schedules 13D/G Reported by ADAR1 Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.